InvestorsHub Logo
Followers 3
Posts 1176
Boards Moderated 0
Alias Born 03/02/2018

Re: RainyDayWriter post# 47928

Wednesday, 03/06/2019 12:24:34 AM

Wednesday, March 06, 2019 12:24:34 AM

Post# of 50157
Continued from previous post:

July, 2017 (continued)

Delcath Systems (OTC:DCTH) is an interventional oncology company focusing on the treatment of liver cancer. It is still doing trials on its Melblez Kit filter system that was failed to be approved by the FDA way back in 2013. The stock is up 1000% over the past month on no news, just recently created hype. The stock closed yesterday at $0.18, reached over $0.30 on June 21st, and was trading between $0.02-$0.04 between May 11th and June 8th.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DCTH News